BFG
TMO icon

Bleakley Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bleakley Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Buy
22,423
+4,479
+25% +$2.15M 0.14% 117
2026
Q1 		$8.82M Sell
17,944
-354
-2% -$192K 0.14% 120
2025
Q4 		$10.6M Buy
18,298
+2,873
+19% +$1.62M 0.18% 94
2025
Q3 		$7.48M Buy
15,425
+1,500
+11% +$698K 0.17% 106
2025
Q2 		$5.65M Sell
13,925
-540
-4% -$226K 0.14% 135
2025
Q1 		$7.2M Buy
14,465
+2,597
+22% +$1.41M 0.23% 83
2024
Q4 		$6.17M Buy
11,868
+812
+7% +$446K 0.19% 92
2024
Q3 		$6.84M Sell
11,056
-13,617
-55% -$8.06M 0.21% 84
2024
Q2 		$13.6M Sell
24,673
-164
-0.7% -$94K 0.39% 44
2024
Q1 		$14.4M Sell
24,837
-5,880
-19% -$3.3M 0.42% 41
2023
Q4 		$16.3M Sell
30,717
-965
-3% -$467K 0.52% 36
2023
Q3 		$16M Buy
31,682
+3,713
+13% +$1.98M 0.57% 34
2023
Q2 		$14.6M Sell
27,969
-1,089
-4% -$588K 0.46% 41
2023
Q1 		$16.7M Buy
29,058
+718
+3% +$405K 0.56% 32
2022
Q4 		$15.6M Buy
+28,340
New +$15M 0.56% 34

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bleakley Financial Group's TMO Position: Q2 2026 in Review

Bleakley Financial Group increased its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, buying an estimated $2.15M and bringing the position to 22,423 shares worth $11.2M. The position accounts for 0.14% of the portfolio, ranked #117.

Bleakley Financial Group first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $16.7M in Q1 2023. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bleakley Financial Group held 22,423 shares of Thermo Fisher Scientific worth $11.2M as of Q2 2026.
  • Bleakley Financial Group bought 4,479 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.15M.
  • Thermo Fisher Scientific made up 0.14% of Bleakley Financial Group's portfolio in Q2 2026, its #117 holding.
  • Bleakley Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Thermo Fisher Scientific position peaked at $16.7M in Q1 2023.
  • 2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.